J Gynecol Oncol.  2013 Oct;24(4):298-302. 10.3802/jgo.2013.24.4.298.

Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010

• Lim MC
• Moon EK
• Shin A
• Jung KW
• Won YJ
• Seo SS
• Kang S
• Kim JW
• Kim JY
• Park SY

• KMID: 2177870
• DOI: http://doi.org/10.3802/jgo.2013.24.4.298

Abstract

OBJECTIVE
To investigate the recent incidence of and trends in cervical, endometrial, and ovarian cancer in Korean females.
METHODS
Data from the Korea Central Cancer Registry between 1999 and 2010 were analyzed. Age-standardized rates (ASRs) and annual percent changes (APCs) were calculated.
RESULTS
The absolute incidence rates of the three major gynecologic cancers increased: 6,394 in 1999 to 7,454 in 2010. The ASR for gynecologic cancer was 23.7 per 100,000 in 1999 and decreased to 21.0 in 2010 (APC, -1.1%; 95% confidence interval [CI], -1.53 to -0.70) due to a definitive decrease in the incidence of cervical cancer (APC, -4.3%). Endometrial cancer has been definitively increasing (APC, 6.9% during 1999-2010), especially in females <30 years old (APC, 11.2%) and in females > or =80 years old (APC, 9.5%). The incidence of ovarian cancer is increasing gradually (APC, 1.5%).
CONCLUSION
ASRs and APC for gynecologic cancers overall are decreasing due to the decrease in the incidence of cervical cancer. However, the incidence of endometrial and ovarian cancer has been increasing.

Keyword

Cancer; Cervix uteri; Endometrium; Ovary; Korea

MeSH Terms

Cervix Uteri
Endometrial Neoplasms
Endometrium
Female
Humans
Incidence
Korea
Ovarian Neoplasms
Ovary
Uterine Cervical Neoplasms

Figure

• 

  Fig. 1 Age-standardized incidence curves of cervical, endometrial, and ovarian cancer, the Korea Central Cancer Registry, 1999-2010.

• 

  Fig. 2 Annual percent changes (APCs) in the incidences of cervical, endometrial, and ovarian cancer according to age group, 1999-2010. Data extraction was based on the definition of the International Classification of Diseases, 10th edition (ICD-10): cervix (C53), endometrium (C54.1), and ovary (C56). *P<0.05.

Reference

1. Lim MC, Seo SS, Kang S, Seong MW, Lee BY, Park SY. Hereditary non-polyposis colorectal cancer/Lynch syndrome in Korean patients with endometrial cancer. Jpn J Clin Oncol. 2010; 40:1121–1127.

2. Lim MC, Kang S, Seo SS, Kong SY, Lee BY, Lee SK, et al. BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients. J Cancer Res Clin Oncol. 2009; 135:1593–1599.

3. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005; 37:325–331.

4. Chung HH, Jang MJ, Jung KW, Won YJ, Shin HR, Kim JW, et al. Cervical cancer incidence and survival in Korea: 1993-2002. Int J Gynecol Cancer. 2006; 16:1833–1838.

5. Chung HH, Hwang SY, Jung KW, Won YJ, Shin HR, Kim JW, et al. Ovarian cancer incidence and survival in Korea: 1993-2002. Int J Gynecol Cancer. 2007; 17:595–600.

6. World Health Organization. International statistical classification of diseases and related health problems. Geneva: World Health Organization;1994.

7. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai, Japan: Tohoku University Press;1960.

8. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2007. Bethesda, MD: National Cancer Institute;2010.

9. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Prediction of cancer incidence and mortality in Korea, 2013. Cancer Res Treat. 2013; 45:15–21.

10. Park B, Choi KS, Lee YY, Jun JK, Seo HG. Trends in cancer screening rates among Korean men and women: results from the Korean National Cancer Screening Survey (KNCSS), 2004-2011. Cancer Res Treat. 2012; 44:113–120.

11. Shin A, Kim KZ, Jung KW, Park S, Won YJ, Kim J, et al. Increasing trend of colorectal cancer incidence in Korea, 1999-2009. Cancer Res Treat. 2012; 44:219–226.

12. Patel A, Galaal K, Burnley C, Faulkner K, Martin-Hirsch P, Bland MJ, et al. Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study. Br J Cancer. 2012; 106:1753–1759.